1. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial;McCormack;Lancet,2016
2. Preexposure prophylaxis for the prevention of HIV infection. IN The United States –2021 update: a clinical practice guideline. Available at: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf.
3. Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies;Schierhout;Lancet Infect Dis,2020
4. The HIV pre-exposure prophylaxis (PrEP) IMPACT trial: baseline demographics, coverage and first regimen choice;Sullivan,2021
5. Geographical distribution of areas with a high prevalence of HTLV-1 infection. Available at: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/geographical-distribution-areas-high-prevalence-HTLV1.pdf.